This handout is for cirrhosis (chronic, compensated + decompensated). Your care team identified this based on: jaundice / scleral icterus.
Other reasons your team may use this plan: new or worsening ascites; variceal bleed — hematemesis / melena; hepatic encephalopathy / confusion / asterixis.
Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.
| Medication | Starting dose | How | When | What it does |
|---|---|---|---|---|
| carvedilol | 6.25 mg PO daily, titrate to 12.5-25 mg BID | PO | daily/BID | Baveno VII — preferred NSBB for primary prophylaxis (better hemodynamic effect than propranolol/nadolol); reduces decompensation |
| propranolol | 20 mg PO BID, titrate to HR 55-60 or max 320 mg/day | PO | BID/TID | Alternative NSBB; longer track record (Baveno VII 2022) |
| nadolol | 20 mg PO daily, titrate to HR 55-60 | PO | daily | Once-daily NSBB option (Baveno VII 2022) |
Plan: Cirrhosis complication-driven regimen — Baveno VII + AASLD 2024
Use these zones to know what to do based on how you feel.
Call 911 or go to the nearest emergency room right away if you have:
Hepatology q3mo decompensated / q6mo compensated; transplant eval at MELD ≥15; addiction services for AUD; vaccinations (HAV/HBV/flu/PNA/COVID); palliative care for advanced (AASLD 2023 Biggins)
Guideline: AASLD 2024 Practice Guidance on Risk Stratification + Portal Hypertension/Varices + AASLD 2023 ACLF + Baveno VII (2022) + AASLD 2023 MASLD + AASLD 2023 HCC + ACG 2023 ALD